
Overview
Deborah Delair is a Pathologist and a Medical Genetics provider in New Hyde Park, New York. Her top areas of expertise are Protein Deficiency, Ruvalcaba Syndrome, Nevoid Basal Cell Carcinoma Syndrome, and Cowden Syndrome.
Her clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is highly rated in 32 conditions, according to our data. His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Erythroderma, Exfoliative Dermatitis, and Tissue Biopsy.
HMH - John Theurer Cancer Center - Hackensack
Martin Gutierrez is a Medical Genetics provider in Hackensack, New Jersey. Dr. Gutierrez is highly rated in 38 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Tissue Biopsy.
Wayne Tam is a Pathologist and a Medical Genetics provider in New Hyde Park, New York. Dr. Tam is highly rated in 10 conditions, according to our data. His top areas of expertise are Temple Syndrome, Tetrasomy 9p, Pallister-Killian Mosaic Syndrome, Chromosome 2 Uniparental Disomy, and Splenectomy.
Frequently Asked Questions about Dr. Deborah F. Delair
Is Dr. Deborah F. Delair a top-rated expert for Protein Deficiency?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Deborah F. Delair is classified as an Experienced expert for Protein Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Deborah F. Delair specialize in?
While Dr. Deborah F. Delair is a Pathology, they have specific expertise in Protein Deficiency, Ruvalcaba Syndrome, and Nevoid Basal Cell Carcinoma Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pathology.
Does Dr. Deborah F. Delair participate in research or clinical trials?
Yes. Dr. Deborah F. Delair has published 53 articles and abstracts on conditions like Protein Deficiency. You can view a list of Dr. Deborah F. Delair's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bannayan-Riley-Ruvalcaba SyndromeDr. Delair isExperienced. Learn about Bannayan-Riley-Ruvalcaba Syndrome.
- Cortical DysplasiaDr. Delair isExperienced. Learn about Cortical Dysplasia.
- Cowden SyndromeDr. Delair isExperienced. Learn about Cowden Syndrome.
- Gastroesophageal Junction CancerDr. Delair isExperienced. Learn about Gastroesophageal Junction Cancer.
- Lhermitte-Duclos DiseaseDr. Delair isExperienced. Learn about Lhermitte-Duclos Disease.
- Nevoid Basal Cell Carcinoma SyndromeDr. Delair isExperienced. Learn about Nevoid Basal Cell Carcinoma Syndrome.


